The Pharmacist

SEPTEMBER 12, 2023

Community pharmacists have been urged to share their views on what a pharmacogenetic service should look like in the UK. Clinical academics in Manchester have launched a new survey seeking healthcare professional’s preferences for the development of a future pharmacogenetic service, as part of an NHS trial. And they have stressed that the involvement of […] The post Pharmacists ‘critical to success’ of future pharmacogenetic service appeared first on The Pharmacist.

Community Pharmacies 93

Community Pharmacies 93

STAT

SEPTEMBER 14, 2023

Long Covid goes by  many names. Today, it is no longer a new public health enigma, but the outlook for sufferers is no better than when the condition was first recognized in early 2020. Although its prevalence has recently decreased to 6% of the U.S. adult population, there has been no significant progress in understanding its causes, prevention, or treatment.

364

364

PharmaVoice

SEPTEMBER 11, 2023

After dropping its neuroscience program earlier this year, the clinical-stage oncology company is doubling down on a candidate targeting the MAPK pathway.

Immunization 246

Immunization Immunity 246

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. The participants were: Dr Tim Sandle, Head of GxP Compliance at Bio Products Laboratory Limited (BPL) as moderator; Dr Edward Tidswell, Executive Director within the Microbiological Quality and Sterility Assurance organisation of Merck & Co; Frederic Ayers, Research Scienti

Documentation 128

Documentation 128

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

BioPharma Dive

SEPTEMBER 11, 2023

The HER3-targeting treatment could become the next antibody-drug conjugate to emerge from Daiichi Sankyo’s laboratories, after the AstraZeneca-partnered Enhertu.

124

124

STAT

SEPTEMBER 12, 2023

A panel of advisers to the Centers for Disease Control and Prevention voted 13-1 Tuesday to recommend updated Covid-19 booster shots for all Americans 6 months and older. CDC Director Mandy Cohen signed off on the recommendation hours later, and vaccines would be available within 48 hours. The recommendation applies to mRNA shots from Pfizer-BioNTech and Moderna, both of which were approved by the Food and Drug Administration Monday.

Vaccines 363

Vaccines 363

European Pharmaceutical Review

SEPTEMBER 15, 2023

The CBL-0201DD Phase II study evaluating the first-in-class small-molecule drug CBL-514 for Dercum’s disease, a rare disorder, has demonstrated significant efficacy in reducing lipoma size and complete clearance. Dercum’s disease is characterised by painful lipomas developing primarily on the trunk in the body. Currently there are no approved or effective medicine, so the data from the Phase II study shows potential of a treatment for this indication.

Compounding 119

Compounding 119

Pharmafile

SEPTEMBER 15, 2023

GSK and Save the Children have announced that they will be renewing their partnership for an additional five years. GSK plans to invest £15m in the partnership, with the two companies working together to increase rates of childhood vaccination. The partnership aims to reduce the number of ‘zero dose’ children in Ethiopia and Nigeria, meaning […] The post GSK and Save the Children extend partnership for unvaccinated children appeared first on Pharmafile.

Vaccines 119

Vaccines 119

STAT

SEPTEMBER 12, 2023

The blazing success of weight loss drugs like Wegovy and Mounjaro has electrified the pursuit of new treatments for obesity. For now, Novo Nordisk and Eli Lilly are leading the market with injectable drugs that target receptors of the GLP-1 hormone to mimic the hormone’s effects of helping people feel full. But dozens of companies are also jumping into the race, seeing the potential to make millions of dollars if they can bring to market medications that are oral, longer-lasting, avoid si

Drug Development 363

Drug Development 363

The Pharmacist

SEPTEMBER 14, 2023

Community pharmacies in Scotland will be able to participate in a national naloxone emergency supply service from the end of next month. The Royal Pharmaceutical Society (RPS) in Scotland described the move as a ‘huge step forwards’ in making naloxone, which is used to reverse the effects of an opioid overdose, available in all clinical […] The post Scotland introduces national naloxone emergency supply appeared first on The Pharmacist.

Community Pharmacies 121

Community Pharmacies 121

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

European Pharmaceutical Review

SEPTEMBER 15, 2023

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. To recognise the influx of innovation across the pharmaceutical industry, three new categories are included in this year’s awards. The shortlisted finalists of the CPHI awards for 2023 include companies that led by example in sustainable manufacturing, manufacturers and innovators that developed new technologies to advance drug discovery, devel

Packaging 119

Packaging Drug Development 119

BioPharma Dive

SEPTEMBER 11, 2023

Pfizer and Moderna, which have seen slowing demand for their coronavirus vaccines, expect to make the reformulated shots available in the U.S. in the coming days.

Vaccines 124

Vaccines 124

STAT

SEPTEMBER 11, 2023

The Food and Drug Administration announced Monday that it had greenlit two   updated Covid-19 booster shots in people as young as 6 months old, triggering a process that could see the Moderna and Pfizer-BioNTech vaccines become available in doctors’ offices, clinics, and pharmacies later this week. The updated approvals relate only to the two messenger RNA vaccines on the U.S. market.

Vaccines 363

Vaccines 363

Express Pharma

SEPTEMBER 12, 2023

JB Chemicals & Pharmaceuticals recently published its 2 nd Sustainability (ESG) Report. The report informs that the overall Green House Gases (GHG) intensity (i.e. Scope 1 and Scope 2) has been reduced by 19 per cent as compared to last year. A statement from the company informs, “This financial year also witnessed the completion of calculating scope 3 emissions for the first time for JB Pharma, where focus will be on total emissions across the organisation and the external supply chain.

116

116

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharma Times

SEPTEMBER 15, 2023

The site will contribute to the development and commercialisation of antibody drugs - News - PharmaTimes

141

141

BioPharma Dive

SEPTEMBER 12, 2023

Arialys Therapeutics launched Tuesday with $58 million in funding from a group of life sciences investors that includes Johnson & Johnson’s venture arm.

Immunization 119

Immunization Immunity 119

STAT

SEPTEMBER 10, 2023

Among people who are still paying attention to Covid-19 , there’s been a recent surge — not just in viral activity but in the concern once again being paid to Covid. Headlines announce that transmission is surging and hospitalizations for Covid are rising by alarming percentages. There’s debate in some places about whether or not to resume wearing masks.

Hospitals 364

Hospitals 364

European Pharmaceutical Review

SEPTEMBER 14, 2023

Under a new agreement, AstraZeneca is set to establish the first unsubsidised industrial-scale supply of biomethane. The pharmaceutical firm is investing greatly in its existing infrastructure to facilitate the shift to renewable gas and support a transition to 100 percent renewable energy. This includes its Macclesfield campus, the UK’s largest pharma manufacturing site.

Pharmaceutical Manufacturing 111

Pharmaceutical Manufacturing 111

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Pharmacist

SEPTEMBER 15, 2023

Health minister Neil O’Brien has agreed to meet with community pharmacy stakeholders following a debate in parliament which centred on the significant challenges across the sector. The debate held yesterday was called by Conservative MP for Waveney Peter Aldous to highlight the role that community pharmacies play and to address the ‘enormous pressures’ they currently […] The post Health minister agrees to meet with pharmacy stakeholders appeared first on The Pharmacist.

Community Pharmacies 111

Community Pharmacies 111

Express Pharma

SEPTEMBER 12, 2023

While there are no marketed drugs for nonalcoholic steatohepatitis (NASH) in the EU or US, most NASH therapies in development primarily focus on treating patients with F2 (moderate fibrosis) or F3 (advanced fibrosis). Of the 33 late-stage pipeline assets in development for NASH, only three focus on decompensated cirrhosis (DC) due to NASH. A further look into the mechanisms of action (MOAs) of each agent reveals that Promethera Biosciences and Cellaion’s HepaStem (heterologous human adult liver

Diabetes 110

Diabetes Immunity Immunization 110

STAT

SEPTEMBER 12, 2023

WASHINGTON — The leading decongestant used by millions of Americans looking for relief from a stuffy nose is no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient. Advisers to the Food and Drug Administration voted unanimously on Tuesday against the effectiveness of the key drug found in popular versions of Sudafed, Allegra, Dayquil and other medications stocked on store shelves.

363

363

Pharma Times

SEPTEMBER 11, 2023

Both companies will work to advance the development of novel radiopharmaceuticals - News - PharmaTimes

138

138

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

BioPharma Dive

SEPTEMBER 13, 2023

The biotech is telling investors it expects to launch as many as 15 new products in five years, a bold goal that will require a lot to go right to pull off.

Drug Development 114

Drug Development 114

FDA Law Blog: Biosimilars

SEPTEMBER 10, 2023

By Mark A. Tobolowsky — CDER, CBER, and the Oncology Center of Excellence recently published a final guidance document titled “ Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products ” as another part of its real-world evidence (“RWE”) Program. This finalized a draft guidance issued in December 2021, largely similar in substance.

Documentation 106

Documentation Vaccines Drug Development 106

STAT

SEPTEMBER 12, 2023

WASHINGTON — There’s a panel of 20 nutrition experts that has outsized influence on the American diet — and the food industry has worked hard to get friendly researchers into the group, new documents obtained by STAT show. The National Potato Council, for example, nominated one of the researchers behind an industry-funded study showing eating french fries each day doesn’t result in more weight gain than eating a comparable amount of almonds.

Documentation 363

Documentation 363

Pharma Times

SEPTEMBER 14, 2023

The report highlights steps needed to ensure future pandemics are handled effectively - News - PharmaTimes

134

134

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

SEPTEMBER 14, 2023

Since 2019, Generate has raised nearly $700 million in private financing and has now brought a monoclonal antibody into Phase 1 testing.

122

122

European Pharmaceutical Review

SEPTEMBER 14, 2023

Rimegepant (Vydura) is the “first and only NICE-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment,” shared Helen Knight, Director of medicines evaluation at the National Institute for Health and Care Excellence (NICE). Made by Pfizer, Rimegepant (Vydura), is recommended in NICE final draft guidance for adults who have tried at least two triptans but failed to achieve adequate relief with these medicines.

105

105

STAT

SEPTEMBER 13, 2023

Over more than a decade working with immigrant farmworkers in the public clinics of the Santa Clara River Valley, Rosemary Hernandez has seen many new moms struggle during the postpartum period. Some were separated from their families in Mexico. Others’ husbands or boyfriends had to head straight back to work picking fruit after the baby arrived.

Compounding 351

Compounding 351

Pharma Times

SEPTEMBER 15, 2023

The method could also be beneficial for Parkinson’s disease and strokes - News - PharmaTimes

135

135

Med Ed 101

SEPTEMBER 13, 2023

One of the most common medication review requests I get from clinical staff in long term care and assisted living facilities is identifying medications that may be contributing to falls. Identifying low blood pressure as a potential contributing factor is usually pretty obvious. It is also obvious to reduce antihypertensive medications (ACEs, ARBs, Diuretics, Calcium […] The post Medications That Cause Low Blood Pressure (Non-Antihypertensives) appeared first on Med Ed 101.

Assisted Living 105

Assisted Living 105